MedTrace Logo

Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions

NCT04560647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2023-04-21

No results posted yet for this study

Summary

The purpose of this study is to understand the role of a specific protein, tumor protein p63 in the skin disease psoriasis. This study is to further understand how psoriasis lesions happens. An understanding of key mediators that lead to psoriasis might aid in the discovery of more effective treatments for this skin disorder. This is not an intervention study. The study is looking to obtain currently untreated plaque psoriasis biopsies and also biopsies from non psoriasis patients. Psoriasis and medical history will be collected then skin biopsies will be obtained from the subjects.

Conditions

Interventions

OTHER

No intervention - Psoriasis Subject

Not currently treated plaque psoriasis patients

OTHER

No intervention - Control Subject

Control subjects without plaque psoriasis and no family history of psoriasis

Sponsors & Collaborators

  • Wright State University

    lead OTHER

Principal Investigators

  • Jeffrey B Travers, MD, PhD · Wright State University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-03
Primary Completion
2023-04-14
Completion
2023-04-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04560647 on ClinicalTrials.gov